<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ContentLora: Life sciences</title><description>New and updated Life sciences pages on ContentLora.</description><link>https://contentlora.com/</link><language>en</language><atom:link href="https://contentlora.com/topics/life-sciences/feed.xml" rel="self" type="application/rss+xml"/><item><title>Amyotrophic lateral sclerosis (ALS)</title><link>https://contentlora.com/wiki/amyotrophic-lateral-sclerosis/</link><guid isPermaLink="true">https://contentlora.com/wiki/amyotrophic-lateral-sclerosis/</guid><description>Reference page on ALS (Lou Gehrig&apos;s disease, a form of motor neurone disease): key facts, genetics, approved drugs, survival and current trials.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>health</category><category>neurotech</category><category>life-sciences</category></item><item><title>Galleri (multi-cancer early detection blood test)</title><link>https://contentlora.com/wiki/galleri-test/</link><guid isPermaLink="true">https://contentlora.com/wiki/galleri-test/</guid><description>Galleri is GRAIL&apos;s blood test that screens for 50+ cancer types. How it works, NHS-Galleri and PATHFINDER 2 results, accuracy and FDA status in 2026.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>health</category><category>life-sciences</category></item><item><title>Karl Deisseroth</title><link>https://contentlora.com/wiki/karl-deisseroth/</link><guid isPermaLink="true">https://contentlora.com/wiki/karl-deisseroth/</guid><description>Karl Deisseroth, Stanford psychiatrist and bioengineer, shares the 2026 Nobel Prize in medicine for optogenetics. His work, CLARITY and mental-health research.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>Neisseria meningitidis (meningococcus)</title><link>https://contentlora.com/wiki/neisseria-meningitidis/</link><guid isPermaLink="true">https://contentlora.com/wiki/neisseria-meningitidis/</guid><description>Neisseria meningitidis causes meningococcal meningitis and sepsis. Its serogroups, who is at risk, US and UK trends in 2025-2026, and vaccines.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>health</category><category>life-sciences</category></item><item><title>Obicetrapib</title><link>https://contentlora.com/wiki/obicetrapib/</link><guid isPermaLink="true">https://contentlora.com/wiki/obicetrapib/</guid><description>Obicetrapib is an oral CETP inhibitor that lowers LDL cholesterol. EU-approved in September 2026 as Ubeslo and Evlarco; PREVAIL outcome data are pending.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>health</category><category>metabolic-medicine</category><category>life-sciences</category></item><item><title>Optogenetics</title><link>https://contentlora.com/wiki/optogenetics/</link><guid isPermaLink="true">https://contentlora.com/wiki/optogenetics/</guid><description>Optogenetics uses light-sensitive algal proteins to switch chosen nerve cells on or off. How it works, what it found, and its first clinical uses.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>PCSK9 inhibitors</title><link>https://contentlora.com/wiki/pcsk9-inhibitors/</link><guid isPermaLink="true">https://contentlora.com/wiki/pcsk9-inhibitors/</guid><description>PCSK9 inhibitors lower LDL cholesterol: evolocumab and alirocumab injections, twice-yearly inclisiran and the 2026 oral pill enlicitide (Lipfendra).</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>health</category><category>metabolic-medicine</category><category>life-sciences</category></item><item><title>Yersinia pestis (plague bacterium)</title><link>https://contentlora.com/wiki/yersinia-pestis/</link><guid isPermaLink="true">https://contentlora.com/wiki/yersinia-pestis/</guid><description>Yersinia pestis is the bacterium that causes plague. How it cycles in rodents and fleas, how it infects people and where it is found today.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>health</category><category>life-sciences</category></item><item><title>ALS research tracker: treatments, trials and milestones</title><link>https://contentlora.com/events/als-research-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/als-research-tracker/</guid><description>A dated, sourced timeline of ALS treatment milestones, from riluzole evidence to tofersen and the September 2026 ulefnersen phase 3 results.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>health</category><category>life-sciences</category><category>neurotech</category></item><item><title>Cancer screening and prevention tracker: 2026 guidelines, trials, FDA: Page created with 2026 timeline through 11 October.</title><link>https://contentlora.com/events/cancer-screening-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/cancer-screening-tracker/</guid><description>A dated, sourced timeline of 2026 cancer screening and prevention news: guideline changes, NHS-Galleri, FDA test decisions and USPSTF upheaval.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>health</category><category>policy</category><category>life-sciences</category></item><item><title>Cholesterol and fasting research tracker 2026: Page created, with timeline through 11 October 2026.</title><link>https://contentlora.com/events/cholesterol-and-fasting-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/cholesterol-and-fasting-tracker/</guid><description>Live tracker of 2026 lipid and fasting news: the new US guideline, oral PCSK9 approval, obicetrapib in the EU, the pelacarsen miss and fasting trials.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>health</category><category>metabolic-medicine</category><category>life-sciences</category></item><item><title>Multi-cancer blood tests: what NHS-Galleri showed and the FDA debate</title><link>https://contentlora.com/analysis/multi-cancer-early-detection-debate/</link><guid isPermaLink="true">https://contentlora.com/analysis/multi-cancer-early-detection-debate/</guid><description>NHS-Galleri missed its main goal but cut stage IV cancers. What the trial data show about multi-cancer blood tests and the views ahead of an FDA decision.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Analysis</category><category>health</category><category>life-sciences</category><category>policy</category></item><item><title>From optogenetics to psychiatry: how close are new treatments?</title><link>https://contentlora.com/analysis/optogenetics-psychiatry-translation/</link><guid isPermaLink="true">https://contentlora.com/analysis/optogenetics-psychiatry-translation/</guid><description>Optogenetics won the 2026 Nobel Prize for revealing brain circuits. How far its findings are from treating depression, anxiety or addiction, and the debate.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Analysis</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>ALS explained: symptoms, diagnosis, treatment and research in 2026</title><link>https://contentlora.com/explain/als-explained/</link><guid isPermaLink="true">https://contentlora.com/explain/als-explained/</guid><description>A plain guide to ALS (Lou Gehrig&apos;s disease): what happens in the body, who gets it, how it is diagnosed, the approved drugs and the 2026 research news.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>neurotech</category><category>life-sciences</category></item><item><title>ALS treatments guide: riluzole, edaravone, tofersen and what&apos;s next</title><link>https://contentlora.com/explain/als-treatments-guide/</link><guid isPermaLink="true">https://contentlora.com/explain/als-treatments-guide/</guid><description>What the trials and regulators found for each ALS drug: riluzole, edaravone, tofersen for SOD1-ALS, withdrawn Relyvrio, and the 2026 ulefnersen results.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category><category>neurotech</category></item><item><title>Home and blood cancer screening tests: FIT vs Cologuard vs Shield</title><link>https://contentlora.com/explain/at-home-cancer-screening-tests-buyers-guide/</link><guid isPermaLink="true">https://contentlora.com/explain/at-home-cancer-screening-tests-buyers-guide/</guid><description>FIT vs Cologuard Plus vs Shield and SimpleScreen blood tests vs Galleri: published accuracy, FDA status and prices as of October 2026. No hands-on testing.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category></item><item><title>Cancer prevention: the evidence on smoking, alcohol, HPV and more</title><link>https://contentlora.com/explain/cancer-prevention-explained/</link><guid isPermaLink="true">https://contentlora.com/explain/cancer-prevention-explained/</guid><description>About 38% of cancers are linked to avoidable risks. Evidence on tobacco, alcohol, body weight, HPV and hepatitis B vaccines and sun protection.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category></item><item><title>Cancer screening in 2026: who should be screened, for what, and when</title><link>https://contentlora.com/explain/cancer-screening-explained/</link><guid isPermaLink="true">https://contentlora.com/explain/cancer-screening-explained/</guid><description>What US (USPSTF) and NHS guidelines recommend for breast, cervical, colorectal, lung and prostate cancer screening in 2026, plus benefits and harms.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category></item><item><title>Cancer warning signs: symptoms that should be checked by a doctor</title><link>https://contentlora.com/explain/cancer-warning-signs/</link><guid isPermaLink="true">https://contentlora.com/explain/cancer-warning-signs/</guid><description>Possible early signs of cancer listed by the NCI and NHS, why most have other causes, and when to see a doctor. Sourced, plain-language guide.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category></item><item><title>Cholesterol-lowering drugs: statins, PCSK9, Lipfendra and more</title><link>https://contentlora.com/explain/cholesterol-lowering-drugs-guide/</link><guid isPermaLink="true">https://contentlora.com/explain/cholesterol-lowering-drugs-guide/</guid><description>A sourced guide to statins, ezetimibe, bempedoic acid, PCSK9 drugs, inclisiran, oral enlicitide (Lipfendra) and obicetrapib: how they work and the evidence.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>metabolic-medicine</category><category>life-sciences</category></item><item><title>Lipoprotein(a) explained: the inherited cholesterol risk</title><link>https://contentlora.com/explain/lipoprotein-a-explained/</link><guid isPermaLink="true">https://contentlora.com/explain/lipoprotein-a-explained/</guid><description>What Lp(a) is, why it is mostly genetic, why every adult is now advised to test once, and what the 2026 pelacarsen trial failure means for treatment.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>metabolic-medicine</category><category>life-sciences</category></item><item><title>Meningitis explained: symptoms, types, treatment and prevention</title><link>https://contentlora.com/explain/meningitis-explained/</link><guid isPermaLink="true">https://contentlora.com/explain/meningitis-explained/</guid><description>What meningitis is, the bacterial and viral types, warning signs including the glass test, how it is treated and which vaccines prevent it.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category></item><item><title>Meningitis vaccines compared: MenACWY, MenB, MenABCWY, PCV and Hib</title><link>https://contentlora.com/explain/meningitis-vaccines-guide/</link><guid isPermaLink="true">https://contentlora.com/explain/meningitis-vaccines-guide/</guid><description>A sourced comparison of meningitis vaccines: what MenACWY, MenB, pentavalent MenABCWY, pneumococcal and Hib vaccines cover, who they are for and the evidence.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category></item><item><title>Plague explained: how it spreads, symptoms and treatment</title><link>https://contentlora.com/explain/plague-explained/</link><guid isPermaLink="true">https://contentlora.com/explain/plague-explained/</guid><description>What plague is, how Yersinia pestis spreads, the bubonic, pneumonic and septicaemic forms, how it is treated and where cases still occur.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>health</category><category>life-sciences</category></item><item><title>Stress and the body: what happens, from cortisol to chronic stress</title><link>https://contentlora.com/explain/stress-and-the-body/</link><guid isPermaLink="true">https://contentlora.com/explain/stress-and-the-body/</guid><description>How the stress response works, from adrenaline and the HPA axis to cortisol, why short-term stress helps, and how chronic stress is linked to ill health.</description><pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate><category>Explainer</category><category>mental-health</category><category>health</category><category>life-sciences</category></item><item><title>Alnylam Pharmaceuticals</title><link>https://contentlora.com/wiki/alnylam-pharmaceuticals/</link><guid isPermaLink="true">https://contentlora.com/wiki/alnylam-pharmaceuticals/</guid><description>Alnylam developed the first approved RNAi drug and is a major siRNA drugmaker. Its medicines, the Amvuttra heart approval and its 2026 pipeline.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>AlphaFold</title><link>https://contentlora.com/wiki/alphafold/</link><guid isPermaLink="true">https://contentlora.com/wiki/alphafold/</guid><description>AlphaFold is Google DeepMind&apos;s AI system for predicting protein and biomolecular structures. Versions, accuracy, database and limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>ai-for-science</category><category>life-sciences</category><category>ai</category></item><item><title>Altos Labs</title><link>https://contentlora.com/wiki/altos-labs/</link><guid isPermaLink="true">https://contentlora.com/wiki/altos-labs/</guid><description>Altos Labs is a cell-rejuvenation biotech launched in 2022 with US$3 billion. Its mission, sites, leadership and where it fits in aging research.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Antibody-drug conjugates (ADCs)</title><link>https://contentlora.com/wiki/antibody-drug-conjugates/</link><guid isPermaLink="true">https://contentlora.com/wiki/antibody-drug-conjugates/</guid><description>Antibody-drug conjugates link an antibody to a toxic payload. Not immunotherapy themselves, they are increasingly paired with checkpoint inhibitors.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Base editing</title><link>https://contentlora.com/wiki/base-editing/</link><guid isPermaLink="true">https://contentlora.com/wiki/base-editing/</guid><description>Base editing rewrites a single DNA letter without cutting both strands. How it works, the first patients treated, and pivotal trials in 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>BioNTech</title><link>https://contentlora.com/wiki/biontech/</link><guid isPermaLink="true">https://contentlora.com/wiki/biontech/</guid><description>BioNTech is the Mainz-based company that co-developed the Pfizer-BioNTech COVID-19 vaccine and is now focused on mRNA cancer immunotherapy.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>Bispecific antibodies and T-cell engagers</title><link>https://contentlora.com/wiki/bispecific-t-cell-engagers/</link><guid isPermaLink="true">https://contentlora.com/wiki/bispecific-t-cell-engagers/</guid><description>Bispecific antibodies bind two targets at once, either linking T cells to tumours or pairing PD-1 with VEGF blockade. Approvals and 2026 trial results.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>BRAIN Initiative</title><link>https://contentlora.com/wiki/brain-initiative/</link><guid isPermaLink="true">https://contentlora.com/wiki/brain-initiative/</guid><description>The US BRAIN Initiative funds neurotechnology and brain-mapping research. Its 2013 launch, budget swings from $680 million to $320 million, and 2026 rebound.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>life-sciences</category><category>health</category></item><item><title>CagriSema (cagrilintide and semaglutide)</title><link>https://contentlora.com/wiki/cagrisema/</link><guid isPermaLink="true">https://contentlora.com/wiki/cagrisema/</guid><description>CagriSema combines the amylin analogue cagrilintide with semaglutide. Novo Nordisk&apos;s REDEFINE results, the miss against tirzepatide and its FDA review.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Calico Life Sciences</title><link>https://contentlora.com/wiki/calico-life-sciences/</link><guid isPermaLink="true">https://contentlora.com/wiki/calico-life-sciences/</guid><description>Calico is the aging research company Google announced in 2013. Its mission, AbbVie partnership, pipeline and 2026 milestones.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>CAR-T cell therapy</title><link>https://contentlora.com/wiki/car-t-cell-therapy/</link><guid isPermaLink="true">https://contentlora.com/wiki/car-t-cell-therapy/</guid><description>CAR-T cell therapy: engineered T cells approved for blood cancers since 2017. Approvals, safety rules, the 2026 solid-tumour first and what comes next.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Casgevy (exa-cel)</title><link>https://contentlora.com/wiki/casgevy/</link><guid isPermaLink="true">https://contentlora.com/wiki/casgevy/</guid><description>Casgevy is the first approved CRISPR medicine, an edited stem cell therapy for sickle cell disease and beta-thalassemia. Approvals, data and status.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Cell-free protein synthesis</title><link>https://contentlora.com/wiki/cell-free-protein-synthesis/</link><guid isPermaLink="true">https://contentlora.com/wiki/cell-free-protein-synthesis/</guid><description>Cell-free systems express genes in a tube using extracted cellular machinery. Yields, uses in circuit prototyping and on-demand production, and 2026 funding.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>synthetic-biology</category><category>life-sciences</category><category>science</category></item><item><title>CEPI (Coalition for Epidemic Preparedness Innovations)</title><link>https://contentlora.com/wiki/cepi/</link><guid isPermaLink="true">https://contentlora.com/wiki/cepi/</guid><description>CEPI funds vaccines against epidemic threats and leads the 100 Days Mission. Its role in mRNA and pandemic preparedness, and its 2027-2031 plan.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>CRISPR-Cas9</title><link>https://contentlora.com/wiki/crispr-cas9/</link><guid isPermaLink="true">https://contentlora.com/wiki/crispr-cas9/</guid><description>CRISPR-Cas9 is the RNA-guided DNA-cutting tool behind modern gene editing and the first approved CRISPR medicine. Origins, uses and limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>CRISPR Therapeutics</title><link>https://contentlora.com/wiki/crispr-therapeutics/</link><guid isPermaLink="true">https://contentlora.com/wiki/crispr-therapeutics/</guid><description>CRISPR Therapeutics is the Swiss-based gene-editing company behind Casgevy with Vertex, now running in vivo CRISPR trials in heart and liver disease.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Eli Lilly and Company</title><link>https://contentlora.com/wiki/eli-lilly/</link><guid isPermaLink="true">https://contentlora.com/wiki/eli-lilly/</guid><description>Eli Lilly makes tirzepatide (Mounjaro, Zepbound) and the GLP-1 pill Foundayo, and is developing retatrutide. Its 2026 results, pipeline and pricing.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Enzymatic DNA synthesis</title><link>https://contentlora.com/wiki/enzymatic-dna-synthesis/</link><guid isPermaLink="true">https://contentlora.com/wiki/enzymatic-dna-synthesis/</guid><description>Enzymatic DNA synthesis uses polymerases instead of phosphoramidite chemistry to write DNA. Its length claims, pricing and 2026 commercial status.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>synthetic-biology</category><category>life-sciences</category><category>science</category></item><item><title>ER-100 (Life Biosciences&apos; reprogramming therapy)</title><link>https://contentlora.com/wiki/er-100/</link><guid isPermaLink="true">https://contentlora.com/wiki/er-100/</guid><description>ER-100 is the first partial epigenetic reprogramming therapy tested in people, in a Phase 1 trial in glaucoma and NAION. Design, early data and caveats.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Ginkgo Bioworks</title><link>https://contentlora.com/wiki/ginkgo-bioworks/</link><guid isPermaLink="true">https://contentlora.com/wiki/ginkgo-bioworks/</guid><description>Ginkgo Bioworks sells cell engineering services, lab automation and datasets. Its 2026 finances, restructuring and pivot to automation and government work.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>synthetic-biology</category><category>life-sciences</category><category>science</category></item><item><title>Immune checkpoint inhibitors</title><link>https://contentlora.com/wiki/immune-checkpoint-inhibitors/</link><guid isPermaLink="true">https://contentlora.com/wiki/immune-checkpoint-inhibitors/</guid><description>Checkpoint inhibitors such as pembrolizumab release immune brakes like PD-1 and CTLA-4. How they work, who responds, side effects and 2026 approvals.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>In vivo CAR-T</title><link>https://contentlora.com/wiki/in-vivo-car-t/</link><guid isPermaLink="true">https://contentlora.com/wiki/in-vivo-car-t/</guid><description>In vivo CAR-T aims to make CAR-T cells inside the body with one infusion, skipping cell manufacturing. Early 2025-2026 myeloma data, safety and limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Intellia Therapeutics</title><link>https://contentlora.com/wiki/intellia-therapeutics/</link><guid isPermaLink="true">https://contentlora.com/wiki/intellia-therapeutics/</guid><description>Intellia Therapeutics develops in vivo CRISPR therapies. Lonvo-z for hereditary angioedema is under FDA review; nex-z trials resumed after a 2025 hold.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>NIA Interventions Testing Program (ITP)</title><link>https://contentlora.com/wiki/interventions-testing-program/</link><guid isPermaLink="true">https://contentlora.com/wiki/interventions-testing-program/</guid><description>The NIA Interventions Testing Program tests candidate anti-aging compounds in genetically diverse mice at multiple sites. Its design and key results.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Intismeran autogene (mRNA-4157/V940)</title><link>https://contentlora.com/wiki/intismeran-autogene/</link><guid isPermaLink="true">https://contentlora.com/wiki/intismeran-autogene/</guid><description>Intismeran autogene is Moderna and Merck&apos;s personalised mRNA cancer therapy. What it is and its 2026 phase 3 melanoma results.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item></channel></rss>